122 related articles for article (PubMed ID: 16353616)
1. No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity.
Visser M; Seidell JC; Koppeschaar HP; Smits P
Obes Res; 1994 Mar; 2(2):152-9. PubMed ID: 16353616
[TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
3. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
Després JP; Ross R; Boka G; Alméras N; Lemieux I;
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
[TBL] [Abstract][Full Text] [Related]
4. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
Finer N; James WP; Kopelman PG; Lean ME; Williams G
Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
[TBL] [Abstract][Full Text] [Related]
5. The metabolic effects of preferential reduction of visceral adipose tissue in abdominally obese men.
Marks SJ; Chin S; Strauss BJ
Int J Obes Relat Metab Disord; 1998 Sep; 22(9):893-8. PubMed ID: 9756248
[TBL] [Abstract][Full Text] [Related]
6. Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
[TBL] [Abstract][Full Text] [Related]
7. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
[TBL] [Abstract][Full Text] [Related]
10. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
11. Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
Cabrera-Rode E; Rodríguez J; Álvarez A; Echevarría R; Reyes AD; Cubas-Dueñas I; Turcios-Tristá SE; Díaz-Díaz O
J Diet Suppl; 2017 Nov; 14(6):626-639. PubMed ID: 28384000
[TBL] [Abstract][Full Text] [Related]
12. The effect of fluoxetine on body weight, body composition and visceral fat accumulation.
Visser M; Seidell JC; Koppeschaar HP; Smits P
Int J Obes Relat Metab Disord; 1993 May; 17(5):247-53. PubMed ID: 8389333
[TBL] [Abstract][Full Text] [Related]
13. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
14. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
Fagerberg B; Berglund A; Andersson OK; Berglund G
J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
[TBL] [Abstract][Full Text] [Related]
15. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women.
Crowther NJ; Ferris WF; Ojwang PJ; Rheeder P
Clin Endocrinol (Oxf); 2006 May; 64(5):535-41. PubMed ID: 16649973
[TBL] [Abstract][Full Text] [Related]
16. Relationship of obesity and body fat distribution with ceruloplasmin serum levels.
Cignarelli M; DePergola G; Picca G; Sciaraffia M; Pannacciulli N; Tarallo M; Laudadio E; Turrisi E; Giorgino R
Int J Obes Relat Metab Disord; 1996 Sep; 20(9):809-13. PubMed ID: 8880346
[TBL] [Abstract][Full Text] [Related]
17. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
Hackman RM; Havel PJ; Schwartz HJ; Rutledge JC; Watnik MR; Noceti EM; Stohs SJ; Stern JS; Keen CL
Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
[TBL] [Abstract][Full Text] [Related]
18. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women.
Rissanen P; Hämäläinen P; Vanninen E; Tenhunen-Eskelinen M; Uusitupa M
Int J Obes Relat Metab Disord; 1997 May; 21(5):367-71. PubMed ID: 9152738
[TBL] [Abstract][Full Text] [Related]
19. A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
Han Y; Kwon EY; Yu MK; Lee SJ; Kim HJ; Kim SB; Kim YH; Choi MS
Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385054
[TBL] [Abstract][Full Text] [Related]
20. [Effects of sibutramine on blood glucose and lipids, body fat mass and insulin resistance in obese patients: a multi-center clinical trial].
Tong NW; Ran XW; Li QF; Tang BD; Li R; Yang FY; Liu YP; Li XJ
Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):659-63. PubMed ID: 16202254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
